HIV Testing and Treatment to Prevent Onward HIV Transmission Among MSM and Transgender Women in Lima, Peru
Phase of Trial: Phase IV
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SABES
- 31 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2020.
- 31 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2020.
- 16 Feb 2017 Preliminary results (n=88) assessing effect of early initiation of ART on neurocognitive performance, presented at the 24th Conference on Retroviruses and Opportunistic Infections